Patient Support & Resources

Three of the main factors currently influencing patient support services are population health management, patient engagement, and shifting perspectives in biopharma, Tracy Foster told a roomful of attendees recently at the 2015 Patient Assistance & Access Programs meeting held in Baltimore, MD. Read More ›

Gilead offers eligible patients receiving treatment with Zydelig (idelalisib) ease of access, affordability, and adherence support through its patient assistance program, Zydelig AccessConnect. Zydelig is a kinase inhibitor approved for the treatment of relapsed follicular B-cell non-Hodgkin lymphoma, relapsed small lymphocytic lymphoma, and in combination with rituximab in the treatment of relapsed chronic lymphocytic leukemia. Read More ›

Patient portals offer valuable benefits to providers and patients by enhancing patient–provider communication, increasing operational efficiencies, and empowering patients, according to data presented at the 2014 Association of Community Cancer Centers National Oncology Conference. Read More ›

San Diego, CA—Patient portals offer valuable benefits to providers and patients by enhancing patient–provider communication, increasing operational efficiencies, and empowering patients, according to data presented at the 2014 Association of Community Cancer Centers National Oncology Conference. Read More ›

GlaxoSmithKline (GSK) offers support programs to patients with cancer in the United States or Puerto Rico. Through its Commitment to Access program, patients prescribed GSK medications potentially have access to free medicine, reimbursement support, or copay assistance. The programs differ in structure for federally insured, privately insured, and uninsured patients. Read More ›

Patients with rheumatic, immune-­mediated, inflammatory diseases require extensive and ongoing assessments of their disease state in response to treatment, providing opportunities for nurse–patient education. Evolution of healthcare has led from treatment on an acute-care basis to patients receiving comprehensive care of their chronic condition in a specialized clinic. Read More ›

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide, seeking to deliver innovative and life-changing treatments. As part of this commitment, the company aims to provide patients who are prescribed Otezla a positive product experience through specialty pharmacy partnerships, 501(c)(3) foundation support, educational materials, and Otezla SupportPlus, a comprehensive patient assistance program. Read More ›

This article is the first in a series of 5 articles to run in Oncology Practice Management on patient assistance programs. The information below—highlighting an assistance program for patients who are prescribed Im­­bruvica—was provided by Phar­macyclics, Inc, and Janssen Biotech, Inc. Read More ›

Establishing a patient-centered approach is rapidly becoming a core requirement in US medical practi­ces. Whether medical home models, accountable care organization (ACO) models, Health Information Technology for Economic and Clinical Health (HITECH) requirements, or new Commission on Cancer standards, all have components of engaging patients in their care. Read More ›

Subscribe to
Rheumatology Practice Management

Stay up to date with rheumatology news & updates by subscribing to receive the free RPM print publications or weekly e‑Newsletter.

I'd like to receive: